(BPT) - People diagnosed with cancer face many questions about the right treatment for their individual disease. Genomic Health has developed its Oncotype DX® genomic-based diagnostic tests to help guide treatment options for breast, colon and prostate cancers. These tests are transforming the quality of cancer care by helping patients receive life-saving treatment while avoiding unnecessary treatment — resulting in improved patient outcomes and reduced healthcare costs. Visit www.OncotypeIQ.com/healthcaresavings to learn more about how these tests can help guide treatment decisions and whether they might be suitable for you or your loved one with cancer.
The Cost Savings of Using Genomic Tests to Personalize Cancer Treatment
July 26, 2019 at 06:36 AM EDT
2019-07-25T11:01:00